← Browse by Condition
Medical Condition
aml adult
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 1
NCT06022003 Phase 2
Recruiting
Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia
Enrollment
33 pts
Location
France
Sponsor
French Innovative Leukemia Org...
NCT06027853 Phase 1
Recruiting
Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia
Enrollment
24 pts
Location
China
Sponsor
Zhejiang University
NCT06263387
Recruiting
Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (IC), Treated With Venetoclax Azacitidine
Enrollment
230 pts
Location
France
Sponsor
French Innovative Leukemia Org...